COST
74
4
CB
53
-8
SO
86
2
CAH
43
3
CMS
71
3
PBI
53
-15
BDX
49
-8
SLG
63
4
SPG
68
2
GIS
63
3
DIS
47
2
CAG
50
-3
TGT
66
3
NSC
50
8
MHK
59
4
PGR
75
-2
STX
57
4
APD
60
15
PNR
71
2
CHK
34
3
COST
74
4
CB
53
-8
SO
86
2
CAH
43
3
CMS
71
3
PBI
53
-15
BDX
49
-8
SLG
63
4
SPG
68
2
GIS
63
3
DIS
47
2
CAG
50
-3
TGT
66
3
NSC
50
8
MHK
59
4
PGR
75
-2
STX
57
4
APD
60
15
PNR
71
2
CHK
34
3
Financhill
Back

Harmony Biosciences Holdings Vs. Amylyx Pharmaceuticals Industry Stock Comparison

Buy
77

HRMY
Harmony Biosciences Holdings

Last Price:
31.16
Seasonality Move:
3.71%
Sell
17

AMLX
Amylyx Pharmaceuticals

Last Price:
1.86
Seasonality Move:
89.63%
Buy
77
Harmony Biosciences Holdings (HRMY) is a Buy

Is Harmony Biosciences Holdings a Buy, Sell or Hold?

  • The current Harmony Biosciences Holdings [HRMY] share price is $31.28. The Score for HRMY is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • HRMY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
17
Amylyx Pharmaceuticals (AMLX) is a Sell

Is Amylyx Pharmaceuticals a Buy, Sell or Hold?

  • The current Amylyx Pharmaceuticals [AMLX] share price is $1.88. The Score for AMLX is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • AMLX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

HRMY Stock Price Chart

What is Harmony Biosciences Holdings's stock price today?

  • The Harmony Biosciences Holdings share price today is $31.28
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HRMY is experiencing selling pressure, which indicates risk of future bearish movement.

AMLX Stock Price Chart

What is Amylyx Pharmaceuticals's stock price today?

  • The Amylyx Pharmaceuticals share price today is $1.88
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMLX is experiencing buying pressure, which is a positive indicator for future bullish movement.

HRMY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.13 Buy
Relative Strength Index (14 RSI): 53.78 Buy
Chaikin Money Flow: -284038 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.16 - 31.08) Buy
Bollinger Bands (100): (30.3 - 33.04) Sell

AMLX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.63 Sell
Relative Strength Index (14 RSI): 27.21 Sell
Chaikin Money Flow: 2385221 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.8 - 2.32) Sell
Bollinger Bands (100): (3.21 - 16.85) Sell

HRMY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.21 Buy
20-day SMA: 30.05 Buy
50-day SMA: 31.02 Buy
200-day SMA: 31.13 Buy
8-day EMA: 31.04 Buy
20-day EMA: 30.66 Buy
50-day EMA: 30.92 Buy
200-day EMA: 32.34 Sell

AMLX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.94 Sell
20-day SMA: 1.94 Sell
50-day SMA: 4.43 Sell
200-day SMA: 14.02 Sell
8-day EMA: 1.94 Sell
20-day EMA: 2.22 Sell
50-day EMA: 4.7 Sell
200-day EMA: 13.04 Sell

Harmony Biosciences Holdings Earnings Growth & HRMY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.11 per share, an increase this year of $0.64 per share, and an increase next year of $1.54 per share.

Amylyx Pharmaceuticals Earnings Growth & AMLX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.96 per share, an increase next quarter of $0.09 per share, a decrease this year of $2.52 per share, and an increase next year of $0.28 per share.

Harmony Biosciences Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Amylyx Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):